| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |